Satellos Bioscience, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 12
- Market Cap
- -
- Website
- http://www.satellos.com
A Long-term Follow-up Study for Participants That Completed the SAT-3247-CL-101 Study
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Satellos Bioscience, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06867107
- Locations
- 🇦🇺
St. Vincent Hospital, Melbourne, Victoria, Australia
First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort
Early Phase 1
Completed
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Drug: matched placebo
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Satellos Bioscience, Inc.
- Target Recruit Count
- 77
- Registration Number
- NCT06565208
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
🇦🇺Veritus, Bayswater, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath